CDKN1B and thyroid cancer: BBR induces cell cycle arrest in human thyroid cancer and glioblastoma cells by upregulating the expression of CIP1/p21 and Kip1/p27 proteins and downregulating cyclin-dependent kinases (CDK2, CDK4, CDK6) (103, 104).